Psychedelics

Federal Money To Support Research On Psychedelics As Alternative To Pills For Chronic Pain Among The Elderly
LSD Microdosing For PMS? After Confirming Antidepressant Effects, Clinical Trials Will Assess If It Addresses Mood Issues
Experts Discuss Botanical Psilocybin's Effect On Neurogenesis And More At Benzinga Cannabis Conference
LSD Microdosing For PMS? After Confirming Antidepressant Effects, Clinical Trials Will Assess If It Addresses Mood Issues
Experts Discuss Botanical Psilocybin's Effect On Neurogenesis And More At Benzinga Cannabis Conference
Podcast - Intro To A Toll-Free Psychedelics Information Line, An Educational Tool By Unlimited Sciences
First Patient Dosed In Psychedelics Therapy Study For Treatment-Resistant Depression

Psychedelics Recent News

DEA Sanctions Religious Use Of Ayahuasca But Refuses Psilocybin For Cancer Patients' Pain Relief
Psychedelic Productivity: Peer Pressure Or Good Career Advice?
A trend of psychedelics being used to improve focus, creativity and general well-being at work is on the rise, especially among a growing group of Silicon Valley entrepreneurs and employees. And, it seems like a last year's warning from the U.S. Food and Drug Administration (FDA) about potential risks associated with compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders is not affecting its popularity.
Colorado Senate Approves Controversial Bill Restricting Social Media Posts On Substances Like Legal Hemp, Psychedelics
Explore how Colorado's SB24-158 bill reshapes social media discussions on legal cannabis, psychedelics, and its debate on free speech rights.
Veterans Affairs Is Not Preventing Suicides Successfully, Says GOP Rep. As Congressional Committee Approves Cannabis And Psychedelics Bills
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Numinus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry Trends
Podcast: Expert Talks About 'Kanna,' The Legal African Succulent That Elevates Awareness, Concentration And More
Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute
Russell Newcombe Dies - Legacy Of UK's Longtime Harm Reduction Advocate, Committed Drug Researcher
Psychedelics Reform Update: Missouri's $10M Budget, Maine's & Maryland's Study Groups, Oregon's Re-Crim And More
DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design
DEA Revisits Proposed Ban On Two Psychedelic Compounds: Researchers Disagree, Insist On Hearings
The Drug Enforcement Administration (DEA) is revisiting its stance on the classification of two psychedelic compounds, 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC), reported Marijuana Moment.  

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Stock Brokers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers